Tazofelone is primarily investigated for its anti-inflammatory properties, making it a potential candidate for treating inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. Its mechanism involves inhibiting leukotriene production, which plays a key role in inflammation. This action helps reduce inflammation in the gastrointestinal tract, alleviating symptoms like pain, diarrhea, and tissue damage. Additionally, research explores its potential in managing other inflammatory conditions, such as arthritis, due to its ability to modulate immune responses. While still under study, Tazofelone shows promise as a therapeutic agent for chronic inflammatory disorders.